Equities

Semler Scientific Inc

Semler Scientific Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)32.63
  • Today's Change-0.12 / -0.37%
  • Shares traded163.87k
  • 1 Year change+24.59%
  • Beta1.0078
Data delayed at least 15 minutes, as of Jul 03 2024 18:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Semler Scientific, Inc. develops, manufactures, and markets products and services that assist in evaluating and treating chronic diseases. The Company provides technology solutions to healthcare providers. The Company's flagship product, QuantaFlo is a four-minute in-office blood flow test. Healthcare providers can use blood flow measurements as part of their examinations of a patient’s vascular condition, including assessments of patients who have vascular disease. QuantaFlo features a sensor clamp that is placed on the toe or finger. Infrared light emitted from the clamp on the dorsal surface of the digit is scattered and reflected by the red blood cells coursing through the area of illumination. Returning light is sensed by the sensor. A blood flow waveform is instantaneously constructed by its proprietary software algorithm. Its customers for QuantaFlo include insurance plans, physician groups, risk assessment groups, hospitals and retailers.

  • Revenue in USD (TTM)65.88m
  • Net income in USD21.69m
  • Incorporated2013
  • Employees92.00
  • Location
    Semler Scientific Inc2340-2348 Walsh Avenue, Suite 2344SANTA CLARA 95051United StatesUSA
  • Phone+1 (408) 627-4557
  • Fax+1 (302) 636-5454
  • Websitehttps://www.semlerscientific.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Inogen Inc321.52m-96.68m190.50m834.00--0.9914--0.5925-4.15-4.1513.818.150.9176.036.83385,519.20-27.57-8.23-34.28-9.5340.5444.54-30.07-10.312.36--0.00---16.32-2.49-22.30--26.34--
Edap Tms SA (ADR)65.29m-19.67m192.95m307.00--3.38--2.96-0.5313-0.53131.761.540.63772.393.53212,684.00-19.21-6.62-26.95-9.2240.9143.23-30.12-9.592.00--0.0757--9.649.05-622.06--32.75--
Outset Medical Inc125.08m-168.77m198.61m480.00--2.13--1.59-3.38-3.382.501.800.35291.823.53260,577.10-47.61-41.40-54.98-47.2924.615.71-134.93-159.055.32-32.130.6786--13.00130.43-6.04--14.27--
Senseonics Holdings Inc23.30m-80.59m207.63m132.00--10.95--8.91-0.1354-0.13540.0390.10670.16352.516.51176,515.20-56.55-73.65-66.90-106.9712.93-40.41-345.89-649.863.70-11.130.4783--36.623.43-142.49---18.76--
Neuropace Inc69.07m-31.51m208.28m171.00--14.50--3.02-1.18-1.182.590.49940.67351.626.63403,935.70-30.72---34.60--73.97---45.61--5.56-4.670.8019--43.72--30.00------
Butterfly Network Inc68.08m-121.92m209.30m225.00--1.03--3.07-0.5893-0.58930.3290.96850.20450.69544.97302,577.80-36.61---42.07--26.50---179.08--3.34--0.00---10.21--20.76------
Cibus Inc2.32m-285.67m213.83m183.00--0.6345--92.17-18.29-18.290.152213.240.0084----12,677.60-129.84-86.28-147.90-96.45-----15,483.49-792.07---3.170.0039--1,057.3350.41-1,484.44--18.53--
Delcath Systems Inc4.61m-49.79m219.79m76.00--13.76--47.71-2.65-2.650.23570.57470.13820.45454.5660,618.42-149.30-116.57-249.28-243.2170.5471.02-1,080.73-1,235.372.25-42.250.3348---24.05-9.53-30.60---5.26--
AngioDynamics, Inc.324.01m-192.37m227.51m815.00--1.05--0.7022-4.78-4.788.105.410.74682.666.46397,555.80-44.34-9.12-54.02-10.1750.1754.23-59.37-19.481.62--0.00--7.135.30-97.54--3.55--
Semler Scientific Inc65.88m21.69m230.56m92.0011.742.9010.323.502.782.788.4511.260.85515.138.51716,097.8028.1438.8331.1444.4189.4390.2232.9232.5812.11--0.00--20.2825.9843.6932.64-0.3821--
Utah Medical Products, Inc.49.04m16.38m234.22m169.0014.721.8610.844.784.514.5113.5035.600.37272.0913.24290,201.2012.4412.6913.0213.1959.0561.5733.3930.5117.89--0.0037.05-3.933.640.98341.659.711.86
Pulmonx Corp72.99m-58.73m244.54m279.00--2.21--3.35-1.54-1.541.912.850.3991.147.81261,627.20-32.11-26.27-35.87-28.9774.3171.95-80.46-93.766.14--0.252--27.9827.98-3.26--20.62--
CVRx Inc42.09m-52.01m253.75m200.00--3.83--6.03-2.48-2.482.013.070.36780.67815.64210,430.00-45.45---48.95--84.45---123.58--10.87-21.110.3064--74.89--0.5528------
Atlantic International Corp0.00-5.00m268.01m7.00---------13.49-13.490.00-1.100.00----0.00-84.66-71.97-128.28-106.09--61.01---1,471.82----1.40---100.00---37.43------
Orchestra Biomed Holdings Inc2.22m-51.64m270.92m56.00--4.74--122.26-1.47-1.470.0631.600.02031.0130.9939,571.43-47.18---52.58--92.06---2,330.46--7.33--0.00---21.88---37.91------
Tactile Systems Technology Inc276.67m28.19m271.60m992.009.661.407.820.98171.181.1811.708.141.016.776.05278,896.2010.300.901512.181.0949.9849.1010.190.83093.63--0.1280.0011.2013.81259.6033.91-23.62--
Data as of Jul 03 2024. Currency figures normalised to Semler Scientific Inc's reporting currency: US Dollar USD

Institutional shareholders

31.12%Per cent of shares held by top holders
HolderShares% Held
Cerity Partners LLCas of 31 Mar 2024701.79k9.93%
The Vanguard Group, Inc.as of 31 Mar 2024310.22k4.39%
BlackRock Fund Advisorsas of 31 Mar 2024280.91k3.98%
LSV Asset Managementas of 31 Mar 2024252.89k3.58%
Acadian Asset Management LLCas of 31 Mar 2024165.88k2.35%
Geode Capital Management LLCas of 31 Mar 2024114.09k1.62%
Jacobs Levy Equity Management, Inc.as of 31 Mar 202498.25k1.39%
Dimensional Fund Advisors LPas of 31 Mar 202493.18k1.32%
SSgA Funds Management, Inc.as of 31 Mar 202491.34k1.29%
Crawford Fund Management LLCas of 31 Mar 202490.05k1.27%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.